Medical and surgical treatment outcomes in patients with chronic rhinosinusitis and immunodeficiency: a systematic review.

Shireen Samargandy Elysia Miriam GroseYvonne ChanEric MonteiroJohn M Lee Jonathan Yip

Published in: International forum of allergy & rhinology (2020)

Patients with CRS and immunodeficiency likely benefit from ESS based on the available evidence. Data supporting medical therapy in this targeted population is limited overall, but there may be a potential role for immunoglobulin therapy in patients with PID and CRS.

Keyphrases

chronic rhinosinusitis
healthcare
electronic health record
type diabetes
stem cells
cancer therapy
machine learning
adipose tissue
insulin resistance
skeletal muscle
glycemic control